Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2 results

Filters applied: . Clear all
Page 1
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Wang T, Zhou Q, Zeng H, Zhang H, Liu Z, Shao J, Wang Z, Xiong Y, Wang J, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Chang Y, Wang X, Xu J. Wang T, et al. Cancer Immunol Immunother. 2020 Sep;69(9):1855-1867. doi: 10.1007/s00262-020-02583-y. Epub 2020 May 4. Cancer Immunol Immunother. 2020. PMID: 32367308 Free PMC article.
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Qi Y, Xia Y, Lin Z, Qu Y, Qi Y, Chen Y, Zhou Q, Zeng H, Wang J, Chang Y, Bai Q, Wang Y, Zhu Y, Xu L, Chen L, Kong Y, Zhang W, Dai B, Liu L, Guo J, Xu J. Qi Y, et al. Cancer Immunol Immunother. 2020 Aug;69(8):1565-1576. doi: 10.1007/s00262-020-02563-2. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306075 Free PMC article.